IGI Logo

Below the Pre-budget expectations from the Pharmaceutical and Healthcare Sector by Kunal Gala, Partner, Deal Value Creation Services, BDO India

“The pharmaceutical and healthcare industries have one of their 2026 projections of the budget, which is changing to domestic capacity resilience and not just export-led incentives. As the global supply chains are pressured, they are considering API production, R&D incentives and accelerating regulatory clearance. Specific fiscal incentives on local manufacturing and innovation would greatly decrease the level of imports. This is not really about subsidies but rather about strategic self-reliance, potential Effects being API self-reliance, Research and development, resiliency of supply chain.”

Above views are of the author and not of the website kindly read disclaimer